MSD
The Senior Principal Scientist will lead scientific strategy for drug conjugate DMPK programs, guiding cross‑functional teams from discovery through clinical candidate nomination and first‑in‑human studies. This role oversees ADME experimentation, portfolio management, and the development of DMPK screening and translational plans while managing a team of investigators and scientific experts.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
35% above the average for this role
MSD ends takeover talks with Revolution Medicines
1 month ago
Senior Principal Scientist
Merck & Co., Inc.
Senior Principal Scientist – DMPK Project Representative
Bristol Myers Squibb
Principal Scientist, ADME Sciences
Digital Biology
ADME&DMPK Senior Scientist
Almirall
Lead Scientific Strategy and Oversight for Drug Conjugate Discovery and Development
Merck & Co., Inc.
Director, ADME
Enveda